A user facility clinical manager reported that a dialyzer blood leak near the end of a patient¿s hemodialysis (hd) treatment.Upon follow up with the charge nurse, it was learned that the dialyzer used was a baxter dialyzer that was not manufactured or distributed by fresenius.The blood leak was noted as being an internal blood leak.The leak was visually observed.The machine, a fresenius 2008k2 machine, did not alarm the blood leak alarm.The patient¿s estimated blood loss (ebl) was approximately 300ml.There was no patient injury, adverse events, or medical intervention required as a result of this event.The patient¿s treatment was ended early due to the blood leak, as the leak occurred very near to the end of scheduled treatment.The fresenius 2008k2 machine was pulled from use and has not yet been returned to service.Due diligence attempts were exhausted, but additional information was not provided regarding if the machine has returned to service and what was done to repair it.
|
Plant investigation: no parts were returned to the manufacturer for physical evaluation.Additionally, no on-site evaluation was performed by a fresenius regional equipment specialist (res).A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the reported problem was not able to be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
|